Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Unknown 2Recruiting 2Completed 2

Sponsor Class

OTHER 33OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

NET 1Head & Neck 1Endocrine 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Neuroendocrine Tumors 1Disease 1

Interventions

apatinib 25Cisplatin 19Capecitabine 17Irinotecan 16Cyclophosphamide 16fludarabine 14Radiotherapy 12Oxaliplatin 12Drug Therapy 12camrelizumab 11Paclitaxel 11S 1 (combination) 10Docetaxel 10Carboplatin 10Fluorouracil 9Blood Specimen Collection 9Bevacizumab 9Nivolumab 8tislelizumab 7Radiation 7Pemetrexed 7Gemcitabine 7Erlotinib Hydrochloride 7Surgical Procedures, Operative 6Neoadjuvant Therapy 6Albumin-Bound Paclitaxel 6toripalimab 5anlotinib 5XELOX 5Tamoxifen 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER_GOV × Positron Emission Tomography Computed Tomography × Clear all
NCT04196985 2021-04-13

HENEPET

Turku University Hospital

Phase NA Unknown
40 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT02621541 2016-01-06

Nonfunctional Pancreatic NET and PET Imaging

Turku University Hospital

Phase 4 Unknown
20 enrolled
EndocrineNET

Disease, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡